Additionally, immunohistochemical (IHC) staining of an expanded cohort of 268 CRC patients showed significantly reduced SLC44A2 expression in CRC tissues compared to adjacent normal colon tissues (Fig. 1F). This evidence concerns the gene SLC44A2 and colorectal carcinoma.